Found: 18
Select item for more details and to access through your institution.
Germline BRCA-Mutated HER2-Negative Advanced Breast Cancer: Overcoming Challenges in Genetic Testing and Clinical Considerations When Using Talazoparib.
- Published in:
- Clinical Breast Cancer, 2023, v. 23, n. 5, p. 469, doi. 10.1016/j.clbc.2023.04.006
- By:
- Publication type:
- Article
Efficacy and Safety of Ribociclib With Letrozole in US Patients Enrolled in the MONALEESA-2 Study.
- Published in:
- 2019
- By:
- Publication type:
- journal article
A Randomized Phase II Trial Investigating the Effect of Platelet Function Inhibition on Circulating Tumor Cells in Patients With Metastatic Breast Cancer.
- Published in:
- Clinical Breast Cancer, 2013, v. 13, n. 6, p. 409, doi. 10.1016/j.clbc.2013.08.006
- By:
- Publication type:
- Article
First-line ribociclib plus letrozole in postmenopausal women with HR+ , HER2− advanced breast cancer: Tumor response and pain reduction in the phase 3 MONALEESA-2 trial.
- Published in:
- Breast Cancer Research & Treatment, 2018, v. 169, n. 3, p. 469, doi. 10.1007/s10549-017-4658-x
- By:
- Publication type:
- Article
Comparative proteogenomic analysis of right-sided colon cancer, left-sided colon cancer and rectal cancer reveals distinct mutational profiles.
- Published in:
- Molecular Cancer, 2018, v. 17, n. 1, p. N.PAG, doi. 10.1186/s12943-018-0923-9
- By:
- Publication type:
- Article
Matched Whole-Genome Sequencing (WGS) and Whole-Exome Sequencing (WES) of Tumor Tissue with Circulating Tumor DNA (ctDNA) Analysis: Complementary Modalities in Clinical Practice.
- Published in:
- Cancers, 2019, v. 11, n. 9, p. 1399, doi. 10.3390/cancers11091399
- By:
- Publication type:
- Article
A phase I trial of the IGF-1R antibody Cixutumumab in combination with temsirolimus in patients with metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 139, n. 1, p. 145, doi. 10.1007/s10549-013-2528-8
- By:
- Publication type:
- Article
A phase II study of UCN-01 in combination with irinotecan in patients with metastatic triple negative breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2013, v. 137, n. 2, p. 483, doi. 10.1007/s10549-012-2378-9
- By:
- Publication type:
- Article
Phase II trial of temsirolimus in patients with metastatic breast cancer.
- Published in:
- Breast Cancer Research & Treatment, 2012, v. 136, n. 2, p. 355, doi. 10.1007/s10549-011-1910-7
- By:
- Publication type:
- Article
Ral signaling pathway in health and cancer.
- Published in:
- Cancer Medicine, 2017, v. 6, n. 12, p. 2998, doi. 10.1002/cam4.1105
- By:
- Publication type:
- Article
Prevention of Everolimus/Exemestane (EVE/EXE) Stomatitis in Postmenopausal (PM) Women with Hormone Receptor-Positive (HR+) Metastatic Breast Cancer (MBC) Using a Dexamethasone-Based Mouthwash (MW): Results of the SWISH Trial.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2016, v. 7, p. 57
- By:
- Publication type:
- Article
Prevention of Everolimus/Exemestane (EVE/EXE) Stomatitis in Postmenopausal (PM) Women with Hormone Receptor-Positive (HR+) Metastatic Breast Cancer (MBC) Using a Dexamethasone-Based Mouthwash (MW): Results of the SWISH Trial.
- Published in:
- Journal of Oncology Navigation & Survivorship, 2016, v. 7, n. 9, p. 57
- By:
- Publication type:
- Article
A Phase 1 study of UCN-01 in combination with irinotecan in patients with resistant solid tumor malignancies.
- Published in:
- Cancer Chemotherapy & Pharmacology, 2011, v. 67, n. 6, p. 1225, doi. 10.1007/s00280-010-1410-1
- By:
- Publication type:
- Article
RECOMMENDATIONS FOR MANAGEMENT OF PI3K ALPHA INHIBITOR-INDUCED HYPERGLYCEMIA BASED ON ALPELISIB TREATMENT EXPERIENCES FROM TWO ACADEMIC INSTITUTIONS.
- Published in:
- Oncology Nursing Forum, 2022, v. 49, n. 2, p. E58, doi. 10.1188/22.ONF.E2
- By:
- Publication type:
- Article
Managing hyperglycemia and rash associated with alpelisib: expert consensus recommendations using the Delphi technique.
- Published in:
- NPJ Breast Cancer, 2024, v. 10, n. 1, p. 1, doi. 10.1038/s41523-024-00613-x
- By:
- Publication type:
- Article
A Cancer and Leukemia Group B Phase II Study of Sunitinib Malate in Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma (CALGB 80603)
- Published in:
- 2010
- By:
- Publication type:
- Journal Article
A Cancer and Leukemia Group B Phase II Study of Sunitinib Malate in Patients with Previously Treated Metastatic Pancreatic Adenocarcinoma (CALGB 80603).
- Published in:
- Oncologist, 2010, v. 15, n. 12, p. 1310, doi. 10.1634/theoncologist.2010-0152
- By:
- Publication type:
- Article
Ezh2, a novel target in detection and therapy of breast cancer.
- Published in:
- OncoTargets & Therapy, 2017, v. 10, p. 2685, doi. 10.2147/OTT.S138777
- By:
- Publication type:
- Article